Signal · Product Feed

Tofogliflozin hydrate etyltransferase Inhibitor II Allosteric inhibition enhances the efficacy

Tofogliflozin hydrate etyltransferase Inhibitor II Allosteric inhibition enhances the efficacy

Name: Tofogliflozin hydrate etyltransferase Inhibitor II Allosteric inhibition enhances the efficacy
Brand: www.ab-travaux.com
SKU: 61224112060
Price: 122.00 USD
Availability: InStock
Rating: 4.7452000000000005 (19 reviews)

SKU: 61224112060

4.7

DKK122.00 DKK161.00

Pay in 4 interest-free payments of $30.50 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 9 - Aug 14

Live Spec

Tofogliflozin hydrate etyltransferase Inhibitor II Allosteric inhibition enhances the efficacyTofogliflozin, also known as CSG 452, is a potent and high selective SGLT2 inhibitor under development the treatment of diabetes mellitus. Tofogliflozin improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus. Tofogliflozin dose dependently suppressed glucose entry into tubular cells. High glucose exposure (30 mM) for 4 and 24 h significantly increased oxidative stress generation in tubular cells, which were

Store: www.ab-travaux.com · Domain: www.ab-travaux.com

Description

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

15-tetraazatricyclo[9

iNOS and COX-2 in A431 cells

MERcK-5 reduces IFN-γ and IL-13

(2005) Nature

Exchange/Return Notes